ArticlePharmaceuticals (Basel, Switzerland)2023

Targeting Protein-Protein Interactions to Inhibit Cyclin-Dependent Kinases.

Mark KleinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.